We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,187

A brochure can fall under the exception to advertising of medicinal products
  • Eversheds LLP
  • European Union
  • May 6 2016

Articles 9 and 10 of the Medicines Act of 25 March 1964 ("Medicines Act") and the Royal Decree of 7 April 1995 relating to the information and


Actualidad Normativa N.º 15 (2016)
  • Gómez-Acebo & Pombo Abogados
  • European Union, Spain
  • April 21 2016

En el ámbito estatal, se ha aprobado el Real Decreto 12016, de 8 de enero, por el que se aprueba la revisión de los Planes Hidrológicos de las


Retail, Food and Hospitality Regulatory Update 17 April 2016 - Important updates
  • DWF LLP
  • European Union, United Kingdom
  • April 17 2016

Primary Authority advice issued to Greggs by Newcastle City Council and confirmed by the first ‘Determination’ of the Better Regulation Delivery


Food, Dietary Supplement & Cosmetics Regulatory Update, Vol. III, Issue 5
  • Jones Day
  • European Union, USA
  • March 24 2016

FDA recently announced a funding opportunity of $19M to states that support the implementation of the Food Safety Modernization Act ("FSMA") Produce


Europe - False Advertising : Avoiding pitfalls in the Life Sciences sector
  • Hogan Lovells
  • European Union
  • February 26 2016

Marketing plays an important role in the success of a company and its products. Globalization and rationalization have made it increasingly common


EMEA Healthcare Industry Group Newsletter - December 2015
  • Baker & McKenzie
  • Belgium, European Union, Germany, Italy, Netherlands, Saudi Arabia, Spain, United Arab Emirates, United Kingdom
  • January 25 2016

The Eurasian Economic Union (EAEU) is introducing major new changes in the marketing of pharmaceuticals across its members - which include Russia


European pharmaceuticals & healthcare newsletter - April 2015
  • Baker & McKenzie
  • European Union, France, Hungary, Italy, United Kingdom
  • April 30 2015

This is a rare example of a major product liability dispute being referred to the European Court of Justice ("ECJ"). The two issues to be decided by


New active substances and global marketing authorisations
  • Taylor Wessing
  • European Union
  • April 20 2015

Data and marketing exclusivity (otherwise known as regulatory data protection) prevents the use of pre-clinical and clinical data produced for the


European Commission clarifies position on post-authorisation efficacy studies
  • Hogan Lovells
  • European Union
  • May 8 2014

On 10 April 2014, the European Commission ("Commission") adopted Commission Delegated Regulation (EU) No 3572014 as regards situations in which


French legal and regulatory update - April 2014
  • Hogan Lovells
  • European Union, France
  • May 1 2014

Draft law granting amnesty for acts committed in the course of social movements and trade unions' protesting activities Filed on November 28, 2012